Group Metacognitive Therapy Versus Mindfulness Meditation Therapy in a Transdiagnostic Patient Sample: A Feasibility Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Hospital Anxiety and Depression Scale (HADS)
研究概览
简要总结
The study will examine the effectiveness of group metacognitive therapy in comparison with group meditation therapy, in patients with Generalised Anxiety Disorder. Individuals will be randomly assigned to either meditation or metacognitive therapy and undergo 8 group therapy sessions of their respective treatment condition.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •individual's score on the GAD-7 & PHQ-9
- •individuals who meet the DSM-IV (Diagnostic and Statistical Manual) criteria for generalized anxiety disorder
排除标准
- •Individuals with major depressive disorder
- •Individuals who report suicidality
- •Individuals with a brain injury or neurological insult
- •Individual who currently engage in substance abuse
- •Individuals with bipolar disorder
- •Individuals with psychotic symptoms
- •Individuals who cannot converse or read English
研究组 & 干预措施
Metacognitive Therapy
Individuals randomly assigned to the metacognitive therapy group will undergo group metacognitive therapy for generalized anxiety disorder.. Individuals will undergo 8 sessions of group therapy lasting approximately 90 minutes.
干预措施: Group Metacognitive Therapy (Behavioral)
Mindfulness Meditation Therapy
Individuals randomly assigned to the mindfulness meditation therapy group will undergo group mindfulness meditation therapy for generalized anxiety disorder. Individuals will undergo 8 sessions of group therapy lasting approximately 90 minutes.
干预措施: Mindfulness Meditation Therapy (Behavioral)
结局指标
主要结局
Hospital Anxiety and Depression Scale (HADS)
时间窗: Administered at pre treatment, mid treatment, post treatment, and 6 month follow up
次要结局
- CAS-I(Administered at pre treatment, mid treatment, post treatment, and 6 month follow up)
- GAD-7(Completed prior to week 1 of treatment.This will be administered prior to treatment as a screening measure for levels of anxiety.)
- PHQ-9(Completed prior to week 1 of treatment.This will be administered prior to treatment as a screening measure for levels of depression.)
研究者
Adrian Wells
Professor of Clinical & Experimental Psychopathology
University of Manchester